Merck Canada says new drug price regulations are unconstitutional
August 23, 2019 at 13:02 PM EDT
Merck Canada and a group of pharmaceutical companies are challenging the constitutionality of new regulations meant to lower patented drug prices, the company said in a statement on Friday, in a late bid to derail reforms that would hurt pharmaceutical companies' earnings.